1. Home
  2. NPKI vs NBTX Comparison

NPKI vs NBTX Comparison

Compare NPKI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$12.98

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.57

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
NBTX
Founded
1932
2003
Country
United States
France
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
NBTX
Price
$12.98
$22.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.17
$8.00
AVG Volume (30 Days)
728.7K
50.1K
Earning Date
10-30-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$259,372,000.00
$11,930,711.00
Revenue This Year
$26.96
N/A
Revenue Next Year
$13.16
$136.64
P/E Ratio
$34.23
N/A
Revenue Growth
25.65
N/A
52 Week Low
$4.76
$2.82
52 Week High
$14.00
$30.35

Technical Indicators

Market Signals
Indicator
NPKI
NBTX
Relative Strength Index (RSI) 59.50 56.36
Support Level $12.84 $20.83
Resistance Level $13.25 $23.77
Average True Range (ATR) 0.34 0.83
MACD 0.06 0.16
Stochastic Oscillator 79.23 72.52

Price Performance

Historical Comparison
NPKI
NBTX

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: